Neomycin and Polymyxin B Sulfates and Dexamethasone Ophthalmic Ointment
Last Updated: July 8, 2016
Status: Current
Products Affected - Description
All presentations are currently available
Reason for the Shortage
- Perrigo has neomycin and polymyxin B sulfates and dexamethasone ophthalmic ointment on shortage due to manufacturing issues.
- Sandoz had neomycin and polymyxin B sulfates and dexamethasone ophthalmic ointment on shortage due to increased demand.
- Valeant had neomycin and polymyxin B sulfates and dexamethasone ophthalmic ointment on shortage due to manufacturing delay.
Available Products
Maxitrol ophthalmic ointment, Alcon Labs
3.5 mg/1 gram - 10,000 unit/1 gram - 1 mg/1 gram 3.5 gram tube, 1 count, (NDC 00065-0631-36)
3.5 mg/1 gram - 10,000 unit/1 gram - 1 mg/1 gram 3.5 gram tube, 1 count, (NDC 00574-4160-35)
3.5 mg/1 gram - 10,000 unit/1 gram - 1 mg/1 gram 3.5 gram tube, 1 count, (NDC 61314-0631-36)
3.5 mg/1 gram - 10,000 unit/1 gram - 1 mg/1 gram 3.5 gram tube, 1 count (NDC 24208-0795-35)
Estimated Resupply Dates
All marketed presentations are available.
Related Shortages
- Cephalexin Oral Suspension — Resolved
- Chloramphenicol Sodium Succinate Injection — Resolved — No Commercially Available Preparations
- Ofloxacin Ophthalmic Solution — No Commercially Available Preparations
- Ofloxacin Otic Solution — No Commercially Available Preparations
- Sulfacetamide and Prednisolone Ophthalmic Ointment — Resolved
Updated
July 8, April 29, January 19 and 15, 2016; November 24, October 21, September 30, 2015, University of Utah, Drug Information Service. Copyright 2016, Drug Information Service, University of Utah, Salt Lake City, UT.